808 related articles for article (PubMed ID: 33839157)
1. Major advances in targeted protein degradation: PROTACs, LYTACs, and MADTACs.
Alabi SB; Crews CM
J Biol Chem; 2021; 296():100647. PubMed ID: 33839157
[TBL] [Abstract][Full Text] [Related]
2. [Induced degradation of proteins by PROTACs and other strategies: towards promising drugs].
Reboud-Ravaux M
Biol Aujourdhui; 2021; 215(1-2):25-43. PubMed ID: 34397373
[TBL] [Abstract][Full Text] [Related]
3. PROTACs: An Emerging Therapeutic Modality in Precision Medicine.
Nalawansha DA; Crews CM
Cell Chem Biol; 2020 Aug; 27(8):998-1014. PubMed ID: 32795419
[TBL] [Abstract][Full Text] [Related]
4. Multifaceted targeted protein degradation systems for different cellular compartments.
Zorca CE; Fallahi A; Luo S; Eldeeb MA
Bioessays; 2022 Jun; 44(6):e2200008. PubMed ID: 35417040
[TBL] [Abstract][Full Text] [Related]
5. The Potential of Proteolytic Chimeras as Pharmacological Tools and Therapeutic Agents.
Coll-Martínez B; Delgado A; Crosas B
Molecules; 2020 Dec; 25(24):. PubMed ID: 33339292
[TBL] [Abstract][Full Text] [Related]
6. Advancing targeted protein degradation for metabolic diseases therapy.
Zhou QQ; Xiao HT; Yang F; Wang YD; Li P; Zheng ZG
Pharmacol Res; 2023 Feb; 188():106627. PubMed ID: 36566001
[TBL] [Abstract][Full Text] [Related]
7. Emerging protein degradation strategies: expanding the scope to extracellular and membrane proteins.
Lin J; Jin J; Shen Y; Zhang L; Gong G; Bian H; Chen H; Nagle DG; Wu Y; Zhang W; Luan X
Theranostics; 2021; 11(17):8337-8349. PubMed ID: 34373745
[TBL] [Abstract][Full Text] [Related]
8. Redefining the Scope of Targeted Protein Degradation: Translational Opportunities in Hijacking the Autophagy-Lysosome Pathway.
Cassidy K; Zhao H
Biochemistry; 2023 Feb; 62(3):580-587. PubMed ID: 34569233
[TBL] [Abstract][Full Text] [Related]
9. Effective degradation of EGFR
Qu X; Liu H; Song X; Sun N; Zhong H; Qiu X; Yang X; Jiang B
Eur J Med Chem; 2021 Jun; 218():113328. PubMed ID: 33773286
[TBL] [Abstract][Full Text] [Related]
10. Advancement of targeted protein degradation strategies as therapeutics for undruggable disease targets.
Kannan MP; Sreeraman S; Somala CS; Kushwah RB; Mani SK; Sundaram V; Thirunavukarasou A
Future Med Chem; 2023 May; 15(10):867-883. PubMed ID: 37254917
[TBL] [Abstract][Full Text] [Related]
11. Prey for the Proteasome: Targeted Protein Degradation-A Medicinal Chemist's Perspective.
Luh LM; Scheib U; Juenemann K; Wortmann L; Brands M; Cromm PM
Angew Chem Int Ed Engl; 2020 Sep; 59(36):15448-15466. PubMed ID: 32428344
[TBL] [Abstract][Full Text] [Related]
12. Progress and Challenges in Targeted Protein Degradation for Neurodegenerative Disease Therapy.
Fang Y; Wang J; Zhao M; Zheng Q; Ren C; Wang Y; Zhang J
J Med Chem; 2022 Sep; 65(17):11454-11477. PubMed ID: 36006861
[TBL] [Abstract][Full Text] [Related]
13. PROTACs, molecular glues and bifunctionals from bench to bedside: Unlocking the clinical potential of catalytic drugs.
Maneiro M; De Vita E; Conole D; Kounde CS; Zhang Q; Tate EW
Prog Med Chem; 2021; 60():67-190. PubMed ID: 34147206
[TBL] [Abstract][Full Text] [Related]
14. Emerging degrader technologies engaging lysosomal pathways.
Ding Y; Xing D; Fei Y; Lu B
Chem Soc Rev; 2022 Oct; 51(21):8832-8876. PubMed ID: 36218065
[TBL] [Abstract][Full Text] [Related]
15. [Advances of targeted protein degradation technology and its applications in diseases therapy].
Chen S; Yang H; Jiang J; Yu S; Li T; Ge S
Sheng Wu Gong Cheng Xue Bao; 2021 Nov; 37(11):3915-3932. PubMed ID: 34841795
[TBL] [Abstract][Full Text] [Related]
16. Targeted protein degradation in drug development: Recent advances and future challenges.
Song J; Hu M; Zhou J; Xie S; Li T; Li Y
Eur J Med Chem; 2023 Dec; 261():115839. PubMed ID: 37778240
[TBL] [Abstract][Full Text] [Related]
17. Targeted Protein Degradation via Lysosomes.
Paudel RR; Lu D; Roy Chowdhury S; Monroy EY; Wang J
Biochemistry; 2023 Feb; 62(3):564-579. PubMed ID: 36130224
[TBL] [Abstract][Full Text] [Related]
18. Mathematical Model for Covalent Proteolysis Targeting Chimeras: Thermodynamics and Kinetics Underlying Catalytic Efficiency.
Chaudhry C
J Med Chem; 2023 May; 66(9):6239-6250. PubMed ID: 37102218
[TBL] [Abstract][Full Text] [Related]
19. Targeted protein degradation directly engaging lysosomes or proteasomes.
Kim J; Byun I; Kim DY; Joh H; Kim HJ; Lee MJ
Chem Soc Rev; 2024 Apr; 53(7):3253-3272. PubMed ID: 38369971
[TBL] [Abstract][Full Text] [Related]
20. PROTACs: past, present and future.
Li K; Crews CM
Chem Soc Rev; 2022 Jun; 51(12):5214-5236. PubMed ID: 35671157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]